Luis Miguel
Antón Aparicio
![Foto de Luis Miguel](/img/nophoto.png)
![Foto de Hospital Universitario Central de Asturias](/img/noimage_org.png)
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Central de Asturias (5)
2015
-
Side effects of targeted therapy
Springer New York, pp. 377-416
2014
-
Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program
Expert Opinion on Drug Safety, Vol. 13, Núm. 9, pp. 1165-1173
2009
-
Comprehensive lung injury pathology induced by mTOR inhibitors
Clinical and Translational Oncology, Vol. 11, Núm. 8, pp. 499-510
2007
-
Cyclooxygenase-2 (COX-2): A molecular target in prostate cancer
Clinical and Translational Oncology, Vol. 9, Núm. 11, pp. 694-702
1983
-
Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 6, Núm. 1, pp. 35-38